Evidence map›Paper›PMID 37181284›Full record

ArticleSovremennye tekhnologii v meditsine2022

Clinical and Pathogenetic Significance of Amylase Level and Microtomographic Index of Synovial Fluid in Various Joint Lesions.

I N Schendrigin, L D Timchenko, I V Rzhepakovsky, S S Avanesyan, M N Sizonenko, W-D Grimm, S N Povetkin, S I Piskov

Open access · diamondAbstract read
In one paragraph

Article in Sovremennye tekhnologii v meditsine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 15 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

I N SchendriginAssociate Professor, Department of Intermediate Level Therapy; Stavropol State Medical University, 310 Mira St., Stavropol, 355017, Russia.
L D TimchenkoProfessor, Chief Researcher, Interdepartmental Scientific and Educational Laboratory of Experimental Immunomorphology, Immunopathology, and Immunobiotechnology; North Caucasian Federal University, 1 Pushkin St., Stavropol, 355017, Russia.
I V RzhepakovskyAssociate Professor, Leading Researcher, Interdepartmental Scientific and Educational Laboratory of Experimental Immunomorphology, Immunopathology, and Immunobiotechnology; North Caucasian Federal University, 1 Pushkin St., Stavropol, 355017, Russia.
S S AvanesyanResearcher, Interdepartmental Scientific and Educational Laboratory of Experimental Immunomorphology, Immunopathology, and Immunobiotechnology; North Caucasian Federal University, 1 Pushkin St., Stavropol, 355017, Russia.
M N SizonenkoResearcher, Interdepartmental Scientific and Educational Laboratory of Experimental Immunomorphology, Immunopathology, and Immunobiotechnology; North Caucasian Federal University, 1 Pushkin St., Stavropol, 355017, Russia.
W-D GrimmProfessor; Witten/Herdecke University, 50 A.-Herrhausen St., Witten, 58448, Germany.
S N PovetkinTraining Master, Department of Physics and Technology of Nanostructures and Materials; North Caucasian Federal University, 1 Pushkin St., Stavropol, 355017, Russia.
S I PiskovLeading Researcher, Interdepartmental Scientific and Educational Laboratory of Experimental Immunomorphology, Immunopathology, and Immunobiotechnology; North Caucasian Federal University, 1 Pushkin St., Stavropol, 355017, Russia.
Institute of Molecular Pathology and Pathomorphology · RUNorth-Caucasus Federal University · RUStavropol State Medical University · RUWitten/Herdecke University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Materials and Methods: Samples of synovial fluid from 95 patients with various joint pathologies at the stage of the disease progression characterized by copious effusion into articular cavities have been examined. Synovial fluid samples obtained by knee arthrocentesis served as a material for the investigation. Conventional methods were used to determine the concentration of uric acid, inorganic phosphorus, total protein, and amylolytic activity level in the selected samples while X-ray density was identified by computed microtomography. Results: All samples of pathological joint fluid have shown a high level of amylolytic activity as compared to the synovial fluid from healthy joints. The relationship between the level of amylolytic activity in synovia and specific joint pathology has been identified. It has also been found that uric acid values, inorganic phosphorus concentrations, and total protein in various types of joint damage may influence X-ray density of the synovial fluid. Correlations between the studied indices have been established. Conclusion: New data on the level of synovia amylolytic activity has been obtained in one non-inflammatory and six different inflammatory diseases. Pathogenically determined correlation between the microtomographic index of synovial fluid density and concentrations of uric acid, inorganic phosphorus, total protein has been confirmed. Specific indicators of X-ray density of synovia in various joint pathologies as well as unidirectional and multidirectional data in comparison with the norm allow us to consider X-ray microtomography as a method that reveals additional details during investigation of synovial fluid density and brings new surrogate markers for the study of pathogenetic mechanisms of the development, differentiation, and treatment of various joint pathologies.

Indexed as

Synovial FluidUric AcidAmylasesHumansKnee JointPhosphorusAmylasesPhosphorusUric Acidamylase activityjoint pathologysynovial fluidX-ray computed microtomographyX-ray density

Identifiers

PMID37181284
PMCPMC10171054
OpenAlexW4312199613

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.